resiquimod has been researched along with galactosamine in 2 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 3,542 | 7 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seki, R | 1 |
| Nishizawa, K; Seki, R | 1 |
2 other study(ies) available for resiquimod and galactosamine
| Article | Year |
|---|---|
Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytokines; Female; Galactosamine; Imidazoles; Immune Tolerance; Immunization; Inflammation; Lectins; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Receptor Cross-Talk; Toll-Like Receptor 2; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9 | 2017 |
Use of TLR9 and TLR7/8 agonists in combination with d-galactosamine in exploring models for distinct severities of systemic inflammation relative to liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Imidazoles; Inflammation; Lipopolysaccharides; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Severity of Illness Index; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9 | 2020 |